This compound is a pharmaceutical intermediate featuring a complex structure with multiple stereocenters, containing an alcohol, aromatic rings, ether groups, and a heterocycle. Its high molecular weight and lipophilicity, along with significant hydrogen bond donor and acceptor capacity, indicate a role in the synthesis of specialized organic molecules for pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 162849-95-8
1-((3R,5r,8r,9r,10s,13s,14s,17s)-3-hydroxy-3,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)ethanone
pharmaceutical intermediate
(alphaR,2R)-3,4-Dihydro-5-[(4-nitrophenyl)methyl]-alpha-phenyl-2H-pyrrole-2-methanol
pharmaceutical intermediate
Tert-butyl (R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboxylate
pharmaceutical intermediate
4-Piperidin-4-ylbenzonitrile
pharmaceutical intermediate
(2S,3S,5S)-5-Amino-2-(N-((5-thiazolyl)-methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane
pharmaceutical intermediate
tert-butyl N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-(1,3-thiazol-5-ylmethoxycarbonylamino)hexan-2-yl]carbamate
NURNDOWJCSUXHT-HVCNVCAESA-N
CC(C)(C)OC(=O)N[C@@H](CC1=CC=CC=C1)C[C@@H]([C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)O